| Name | Title | Contact Details |
|---|---|---|
Charles Schoch |
Interim Chief Financial Officer | Profile |
Dana Shkolny |
Chief Of Staff | Profile |
Ileen Winick |
Chief People Officer | Profile |
Debi Harmon |
Senior Director, Human Resources | Profile |
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company headquartered in Hershey, PA with lab facilities in Rockville, MD. ITI is developing next generation vaccines based on the patented Lysosomal Associated Membrane Protein, or LAMP, Technology. Our LAMP-Vax™ vaccine platform significantly increases the effectiveness of the immune response to nucleic acid vaccines while simplifying overall vaccine design and delivery, yielding safer, more cost-effective human and animal therapies. LAMP emerged from $20 million of NIH-funded research conducted by distinguished scientist Dr. Tom August at the Johns Hopkins University School of Medicine. ITI has the exclusive worldwide license to the LAMP technology patent estate and is commercializing ground-breaking next generation LAMP DNA vaccines, beginning with allergy, cancer and infectious disease.
Aldagen is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Knopp Neurosciences is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Skingenix is a Arcadia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Revolutionary Products for Soft Tissue Replacement and Regeneration